Important Sell Side M&A Lessons

Sell Side M&A Advice

An M&A Science Podcast

Hosted by Kison Patel

“Never underestimate anything.” It’s impossible to know 100% of the business when you first do a transaction. You will always deal with unknowns."

On this episode

Vamsi Maddipatla, the founder and president of LAXAI, shares the biggest lessons he learned from sell side m&a transactions, and what he did differently during buy side deals.

Previously, Maddipatla worked at notable companies such as Deloitte, Pfizer, and Merrill Lynch. And it was in 2005 that he started his own company that focused on data compliance for the pharmaceutical industry.

In this podcast, Maddipatla discusses his sell side experience, how to wisely choose investments, and post-deal integration.

---

Show Notes

0:00 – 4:03 Vamsi’s background at Deloitte, Pfizer, Merrill Lynch

4:04 – 6:27 Acquiring Clinovo (how found and why chose over others)

6:28 – 9:24 Due diligence process as a buyer

9:25 – 11:24 Issues that came up during diligence process

11:25 13:39 Working with the investment banker

13:40 – 14:19 Interaction with seller prior to closing

14:20 – 19:19 Challenges with integration

19:20 – 21:55 Lessons learned and post-closing challenges

21:56 – 23:05 Lessons from the sell side

23:06 – 23:38 What’s on the horizon

Related Content

Subscribe to the M&A Science podcast

DealRoom is a secure, cloud-based M&A software platform that replaces overpriced data rooms, email clutter and manual spreadsheet trackers.

REcommended articles